Sign In
Buy NUS
$5.28
-0.320 (-5.71%)
At Close: Jun 03, 2026
Nu Skin (NUS) Queued for Q3 Earnings: Things to Consider
02:18pm, Monday, 31'st Oct 2022
Nu Skin's (NUS) Q3 performance will likely reflect continued economic uncertainty, prolonged COVID-associated factors, unfavorable currency rates and geopolitical conflicts.
Nu Skin Enterprises (NUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
02:01pm, Wednesday, 26'th Oct 2022 Zacks Investment Research
Nu Skin (NUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nu Skin's (NUS) Focus on Nu Vision 2025 & Product Launches Aids
02:13pm, Friday, 07'th Oct 2022 Zacks Investment Research
Nu Skin (NUS) is optimistic about its Nu Vision 2025 strategy to become the world's leading integrated beauty and wellness company, driven by a dynamic affiliate opportunity platform.
Infosys (INFY) Rides on Digitization Growth and Collaborations
02:15pm, Tuesday, 04'th Oct 2022 Zacks Investment Research
Infosys (INFY) continues to gain from its high-margin digital business solutions and back-to-back strategic collaboration wins.
Insiders Selling Nasdaq, Bristol-Myers Squibb And This Consumer Defensive Stock
03:05pm, Friday, 23'rd Sep 2022 Benzinga
The Nasdaq Composite dropped by around 150 points on Thursday. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it indicates their concern in the company’s pr
Nu Skin (NUS) Down More Than 15% in 3 Months: Here's Why
02:37pm, Tuesday, 06'th Sep 2022 Zacks Investment Research
Nu Skin (NUS) is battling continued economic uncertainty, prolonged COVID-associated factors, unfavorable currency rates and geopolitical conflicts.
Nu Skin (NUS) Down More Than 15% in 3 Months: Here's Why
12:02pm, Tuesday, 06'th Sep 2022
Nu Skin (NUS) is battling continued economic uncertainty, prolonged COVID-associated factors, unfavorable currency rates and geopolitical conflicts.
This Analyst Lowers Price Target On Lyft; Also Check Out Some Other Major PT Changes
11:48am, Monday, 08'th Aug 2022 Benzinga
Wells Fargo cut the price target on Lyft, Inc. (NASDAQ: LYFT) from $49 to $42. However, Wells Fargo analyst Brian Fitzgerald maintained the stock with an Overweight. Lyft shares rose 0.6% to $20.41 i
Nu Skin (NUS) Q2 Earnings Miss Estimates, Trims FY22 View
02:19pm, Friday, 05'th Aug 2022 Zacks Investment Research
Nu Skin's (NUS) second-quarter 2022 earnings and revenues decline year over year. Management lowers the full year view.
Nu Skin (NUS) Q2 Earnings Miss Estimates, Trims FY22 View
12:02pm, Friday, 05'th Aug 2022
Nu Skin's (NUS) second-quarter 2022 earnings and revenues decline year over year. Management lowers the full year view.
Nu Skin Enterprises, Inc. (NUS) CEO Ryan Napierski on Q2 2022 Results - Earnings Call Transcript
11:27pm, Thursday, 04'th Aug 2022
Nu Skin Enterprises, Inc. (NYSE:NUS ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Scott Pond - Vice President of Investor Relations Ryan Napierski - President & Chi
Nu Skin Enterprises (NUS) Q2 Earnings Lag Estimates
11:05pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Nu Skin (NUS) delivered earnings and revenue surprises of -2.53% and 0.13%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Factors Likely to Decide Nu Skin's (NUS) Fate in Q2 Earnings
12:57pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Nu Skin's (NUS) Q2 results are likely to reflect the impacts of COVID-led headwinds in Mainland China, the ongoing conflict between Russia and Ukraine, and the global economic downturn.
Factors Likely to Decide Nu Skin's (NUS) Fate in Q2 Earnings
10:32am, Wednesday, 03'rd Aug 2022
Nu Skin's (NUS) Q2 results are likely to reflect the impacts of COVID-led headwinds in Mainland China, the ongoing conflict between Russia and Ukraine, and the global economic downturn.
Inter Parfums (IPAR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
02:01pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Inter Parfums (IPAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
